![](https://i.kinja-img.com/gawker-media/image/upload/s--AvUdbBCj--/c_fit,fl_progressive,q_80,w_636/bb03e76a19d77870b10525c6fa453702.jpg)
Scientists dosed the first patient this week in a small clinical trial of an experimental cancer treatment—one that relies on a novel kind of ally. The treatment uses a virus engineered to selectively kill cancer cells, while also amplifying the body’s immune response to the cancer. The hope is that this therapy can…